The anti-angiogenic effect of sinomenine

Keyphrases

• Sinomenine 100%
• Antiangiogenic Activity 100%
• Rheumatoid Arthritis 40%
• Human Umbilical Vein Endothelial Cells (HUVECs) 40%
• Basic Fibroblast Growth Factor (bFGF) 20%
• Pharmacological Activities 10%
• China 10%
• Alkaloids 10%
• Inflammation 10%
• Interleukin-1β 10%
• Granulocytic 10%
• Angiogenesis 10%
• Rheumatoid Arthritis Treatment 10%
• HL-60 Cells 10%
• New Therapeutic Strategies 10%
• G1 Phase 10%
• Therapeutic Mechanism 10%
• Immune Response 10%
• Induced Proliferation 10%
• Chemotaxis 10%
• Tube Formation 10%
• Leukocytes 10%
• Antiangiogenic Therapy 10%
• Angiogenesis in Vitro 10%
• Neovascularization 10%
• Immune-mediated Diseases 10%
• Blood Vessel Wall 10%
• Matrigel Plug Assay 10%
• Adhesive Bonding 10%
• Rat Aorta Rings 10%
• Antiangiogenic Properties 10%
• Transmigration 10%
• Chinese Medicinal Plants 10%
• Sinomenium Acutum 10%
• Matrigel 10%
• Antirheumatic Drugs 10%
• Endothelial Monolayer 10%
• Synovial Hyperplasia 10%
• Leukocyte Migration 10%

Immunology and Microbiology

• Inflammatory Arthritis 100%
• Antiangiogenic Activity 100%
• Umbilical Vein Endothelial Cell 80%
• Angiogenesis 40%
• Cell Cycle 20%
• Interleukin 1 20%
• Immune Response 20%
• Leukocyte 20%
• Chemotaxis 20%
• Sprouting 20%
• Neovascularization (Pathology) 20%
• Blood Vessel Wall 20%
• Medicinal Plant 20%
• Sinomenium 20%
• Leukocyte Migration 20%
• Drug Mechanism 20%
• Cell Cycle G1 Phase 20%
• In Vitro 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Sinomenine 100%
• Antiangiogenic 100%
• Rheumatoid Arthritis 50%
• Inflammatory Arthritis 50%
• Matrigel 20%
• Diseases 10%
• Interleukin 1 10%
• Antirheumatic Agent 10%
• Inflammation 10%
• Medicinal Plant 10%
• Anti-Inflammatory Drug 10%
• Hyperplasia 10%
• Antiangiogenic Therapy 10%
• Drug Action 10%
• Adhesive Agent 10%
• Neovascularization (Pathology) 10%
• Sinomenium 10%